ConductScience.org, home

Gene · 5818

NIH grants2,464

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleNECTIN1 papersNewest fiscal year
R01NS110942Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune Microenvironment22025
R35CA210087Human natural killer cells: Advancing biology and clinical applications22025
R35GM140806Pathological Myeloid Activation After Sepsis and Trauma22025
R35GM144275Immune signal perception and integration by cell surface receptors and peptide liga22025
R37AG020719T Cell Homeostasis and Function in Immune Senescence22025
RM1GM139690Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology22025
T32AI007025Infectious Diseases and Microbial Immunology Post-doctoral Training Program22025
T32AI007245Molecular Basis of Viral Infectivity22025
T32AI007363Immunobiology of Myeloid and Lymphoid Cells22025
T32AI007476Immunology and Molecular Pathogenesis Training Program22025
T32AI007496Interdisciplinary Training Program in Immunology22025
T32AI060519Immunology and Infectious Diseases Training Program22025
T32DE007057Tissue Engineering and Regeneration22025
T32GM008721Molecular Biology in Burns and Trauma22025
T32HL007605Research training in respiratory biology22025
T32HL007749Multidisciplinary Training Program in Lung Disease22025
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged22025
U19AI089992Immune signatures of vaccine responses in vulnerable populations22025
U54GM104938Oklahoma Shared Clinical and Translational Resources22025
ZIAAI000430Molecular Biology Of Varicella Zoster Virus Infection22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5818/grants?page=4